liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Screening of circulating microRNA biomarkers for prevalence of abdominal aortic aneurysm and aneurysm growth.
Uppsala University, Uppsala, Sweden .
Uppsala University, Uppsala, Sweden .
Linköping University, Department of Medical and Health Sciences, Division of Drug Research. Linköping University, Faculty of Medicine and Health Sciences.
Jönköping University, Jönköping, Sweden.
Show others and affiliations
2017 (English)In: Atherosclerosis, ISSN 0021-9150, E-ISSN 1879-1484, Vol. 256, 82-88 p.Article in journal (Refereed) Published
Abstract [en]

BACKGROUND AND AIMS: MicroRNA (miR) are important regulators of gene expression and biological processes and have recently been suggested as possible biomarkers for abdominal aortic aneurysm (AAA) disease. The aim of the present study was to assess the role of miR as biomarkers for initiation and progression of AAA disease, through evaluation of a wide range of miRs in a large population-based cohort, with AAA patients with linked clinical data regarding risk factors, AAA size and growth, as well as controls.

METHODS: The expression of the 172 most commonly expressed miRs in plasma was analyzed by real-time PCR in samples from 169 screening-detected AAA patients and 48 age-matched controls.

RESULTS: For 103 miRs, there was a significant difference in expression between AAA and controls. Of these, 20 miRs were differently expressed between fast and slow growing aneurysms. These miRs target genes known to be involved in AAA disease as well as novel genes and pathways. By combining the top altered miRs together with clinical variables, strong predictive values, determining growth of AAA, were obtained (area under curve = 0.86, p < 0.001).

CONCLUSIONS: This large cohort study identified several novel miRs with altered expression in AAA patients when compared to controls. Assessment of miR expression may offer an opportunity to predict disease progression and aneurysm growth.

Place, publisher, year, edition, pages
Elsevier, 2017. Vol. 256, 82-88 p.
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:liu:diva-134655DOI: 10.1016/j.atherosclerosis.2016.11.007ISI: 000393891900012PubMedID: 27993388OAI: oai:DiVA.org:liu-134655DiVA: diva2:1076116
Note

Funding agencies: Swedish Research Council [K2013-99X-22231-01-5, K2013-64X-20406-07-3]; Swedish Heart-Lung Foundation [2012-0353, 2015-0596, 2013-0650]; Ake Wibergs stiftelse [M15-0009]; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse

Available from: 2017-02-22 Created: 2017-02-22 Last updated: 2017-03-27

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Vorkapic, EminaLänne, TosteWågsäter, Dick
By organisation
Division of Drug ResearchFaculty of Medicine and Health SciencesDivision of Cardiovascular MedicineDepartment of Thoracic and Vascular Surgery
In the same journal
Atherosclerosis
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 17 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf